- Report
- February 2026
- 250 Pages
Global
From €3998EUR$4,490USD£3,487GBP
- Report
- January 2026
- 197 Pages
Global
From €3157EUR$3,545USD£2,753GBP
€3508EUR$3,939USD£3,059GBP
- Report
- January 2026
- 181 Pages
Global
From €3157EUR$3,545USD£2,753GBP
€3508EUR$3,939USD£3,059GBP
- Report
- January 2026
- 190 Pages
Global
From €3157EUR$3,545USD£2,753GBP
€3508EUR$3,939USD£3,059GBP
- Report
- May 2026
- 281 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 270 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 282 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 352 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 470 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- January 2026
- 180 Pages
Global
From €4007EUR$4,500USD£3,495GBP
- Report
- January 2026
- 182 Pages
Global
From €4007EUR$4,500USD£3,495GBP
- Report
- May 2026
- 462 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 253 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 320 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 329 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 285 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- May 2026
- 180 Pages
Global
From €5210EUR$5,850USD£4,543GBP
- Report
- February 2026
- 250 Pages
Global
From €3998EUR$4,490USD£3,487GBP
- Report
- February 2026
- 250 Pages
Global
From €3998EUR$4,490USD£3,487GBP
- Report
- February 2026
- 250 Pages
Global
From €3998EUR$4,490USD£3,487GBP

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more